Defined System to Assess the in Vitro Induction of a Psoriasis Phenotype on Normal Keratinocytes by Fibroblasts from Psoriatic Subjects

Abstract

French

Background:

Research has shown that involved as well as uninvolved skin of psoriatic subjects have an inherent defect that manifests, at a minimum, as nonapparent epidermal hyperplasia. Fibroblasts have been shown to regulate epidermal proliferation and differentiation; furthermore, fibroblasts from patients with psoriasis have altered growth, response, and mediator release when compared with normal.

Objective:

We conjectured that it might be possible to generate the enhanced epidermal proliferation inherent to psoriatic skin in vitro using a defined interactive culture system with cellular components from the skin of normal and psoriatic subjects.

Methods:

To reduce the variables whereby fibroblasts stimulate keratinocyte proliferation in vitro, a system was developed that does not permit direct contact between keratinocytes and fibroblasts, but does permit the exchange of media and mediators as well as an assessment of keratinocyte growth as a function of time. Fibroblasts from involved and uninvolved sites from biopsies of seven untreated psoriatic subjects were assessed for their effect on the growth of keratinocytes from normal subjects.

Results:

Analysis shows that five of seven fibroblast sources from involved sites and six of seven from uninvolved sites of psoriatic subjects induce normal keratinocytes to display enhanced outgrowth. Three of 14 fibroblast sources consistently do not induce this change. Fibroblasts from uninvolved sources are particularly effective, with a mean of 40 ± 8% (SD) more growth than with normal fibroblasts.

Conclusion:

It is concluded that fibroblasts from psoriatics can induce the phenotype of increased epidermal proliferation on normal keratinocytes via a soluble mediator in a defined system.

Get full access to this article

View all access options for this article.

References

Krueger

. A perspective of psoriasis as an aberration in skin modified to expression by the inflammatory/repair system. In: Norris

, ed. Immune mechanisms in cutaneous disease. New York: Marcel Dekker, 1989:425–445.

Wrone-Smith

Nickoloff

. Dermal injection of immunocytes induces psoriasis. J Clin Invest 1996; 98:1878–1887.

Krueger

Wolfe

Nabeya-Tsukifuji

. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995; 182:2067–2068.

Kupper

. Mechanisms of cutaneous inflammation. Arch Dermatol 1989; 125:1406–1412.

Sporn

Roberts

. Peptide growth factors and inflammation, tissue repair, and cancer. J Clin Invest 1986; 78:329–332.

Goustin

Leof

Shipley

. Growth factors and cancer. Cancer Res 1986; 46:1015–1029.

Adzick

Lorenz

. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann Surg 1994; 220:10–18.

MacNeil

. What role does the extracellular matrix serve in skin grafting and wound healing? Burns 1994; 20:S67–S70.

Krueger

Jorgensen

Bradshaw

. An approach for and an assessment of interactive communication via cytokines of cellular components of skin. Proceedings of the International Symposium on Chemical Mediators in Skin Inflammation, Sendai, Japan, August 1988. Dermatologica 1989; 179:91–100.

10.

Mackenzie

Fusenig

. Regeneration of organized epithelial structure. J Invest Dermatol 1983; 81:189s–194s.

11.

Worst

Mackenzie

Fusenig

. Reformation of organized epidermal structure by transplantation of suspensions and cultures of epidermal and dermal cells. Cell Tissue Res 1982; 225:65–77.

12.

Raynaud

Evain

. Increased chemotactic and mitogenic response of psoriatic fibroblasts to platelet-derived growth factor. J Invest Dermatol 1988; 91:599–602.

13.

Priestley

. Hyperactivity of fibroblasts cultured from psoriatic skin: II. Synthesis of macromolecules. Br J Dermatol 1983; 109:157–164.

14.

Priestley

Adams

. Hyperactivity of fibroblasts cultured from psoriatic skin: I. Faster proliferation and effect of serum withdrawal. Br J Dermatol 1983; 109:149–156.

15.

Priesdey

Adams

. Mitogenic effects of sera from normal and psoriatic subjects on human skin fibroblasts. Arch Dermatol Res 1985; 227:13–15.

16.

Charveron

Bonafe

. Increased superoxide anion production in dermal fibroblasts of psoriatic patients. Skin Pharmacol 1993; 6:253–258.

17.

Saiag

Coulomb

Lebreton

. Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 1985; 230:669–672.

18.

Konstantinova

Duong

DMT

Remenyik

. Interleukin-8 is induced in skin equivalents and is highest in those derived from psoriatic fibroblasts. J Invest Dermatol 1996; 107:615–621.

19.

Rico

Halprin

Baker

. Stimulated mitotic counts in the non-lesional skin of patients with psoriasis and controls. Br J Dermatol 1985; 113:185–188.

20.

Fraki

Briggaman

Lazarus

. Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice. Science 1982; 215:685–687.

21.

Krueger

Chambers

Shelby

. Involved and uninvolved skin from psoriatic subjects: Are they equally diseased? J Clin Invest 1981; 68:1548–1557.

22.

Harper

Rispler

Urbanek

. DNA synthesis among uninvolved and involved psoriatic epidermal cells and normal epidermal cells in vitro. J Invest Dermatol 1978; 70:254–256.

23.

Baker

Brent

Valdimarsson

. Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T-cell derived cytokines? Br J Dermatol 1992; 126:105–110.

24.

Nanney

Yates

King

. Modulation of epidermal growth factor receptors in psoriatic lesions during treatment with topical EGF. J Invest Dermatol 1992; 98:296–301.

25.

Priestley

Lord

. Fibroblast-keratinocyte interactions in psoriasis: Failure of psoriatic fibroblasts to stimulate keratinocyte proliferation in vitro. Br J Dermatol 1990; 123:467–472.